NVST Envista Holdings Corp
NYSE · SEC CIK 1757073 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $510.2K 2 sales by 1 insiders
- Filings on record
- 186 since 2021-07-16, latest 2026-08-27 16:25
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Reis Mischa | SVP, Strategy, Bus. Dev | — | $510.2K |
| Acurio Veronica | Pres, Orthodontics | — | — |
| Nilsson Stefan | Pres, Nobel Biocare | — | — |
| Befidi Robert | Pres, Diagnostics | — | — |
| Kaabi Faez C | CAO | — | — |
| Pierce James Andrew | Dir | — | — |
| Nance Mark E | GC | — | — |
| Keel Paul A | CEO, Dir | — | — |
| Hammes Eric D. | CFO | — | — |
| Carruthers Wendy | Dir | — | — |
Transactions 208
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-27 16:25 | 2026-08-25 | NVST | Acurio Veronica | Pres, Orthodontics | F - Tax | $27.47 | -7,710 | 48.8K | -14% | -$211.8K | |
| 2026-08-27 16:23 | 2026-08-25 | NVST | Befidi Robert | Pres, Diagnostics | F - Tax | $27.47 | -5,147 | 45.8K | -10% | -$141.4K | |
| 2026-08-27 16:21 | 2026-08-25 | NVST | Hammes Eric D. | CFO | F - Tax | $27.47 | -10.9K | 99.9K | -10% | -$299.0K | |
| 2026-08-27 16:19 | 2026-08-25 | NVST | Nilsson Stefan | Pres, Nobel Biocare | F - Tax | $27.47 | -804 | 61.6K | -1% | -$22.1K | |
| T | 2026-08-24 16:25 | 2026-08-20 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | S - Sale | $27.50 | -8,000 | 27.3K | -23% | -$220.0K |
| D | 2026-08-20 16:15 | 2026-08-18 | NVST | Keel Paul A | CEO, Dir | A - Grant | $0.00 | +179.7K | 551.3K | +48% | $0 |
| 2026-05-27 16:17 | 2026-05-25 | NVST | Keel Paul A | CEO, Dir | F - Tax | $23.43 | -12.8K | 371.6K | -3% | -$300.2K | |
| 2026-05-21 16:37 | 2026-05-19 | NVST | Carruthers Wendy | Dir | A - Grant | $0.00 | +9,330 | 59.9K | +18% | $0 | |
| 2026-05-21 16:37 | 2026-05-19 | NVST | TSINGOS CHRISTINE A | Dir | A - Grant | $0.00 | +9,330 | 59.9K | +18% | $0 | |
| 2026-05-21 16:37 | 2026-05-19 | NVST | Jain Vivek | Dir | A - Grant | $0.00 | +9,330 | 52.9K | +21% | $0 | |
| 2026-05-21 16:37 | 2026-05-19 | NVST | GALLAHUE KIERAN | Dir | A - Grant | $0.00 | +9,330 | 54.0K | +21% | $0 | |
| 2026-05-21 16:37 | 2026-05-19 | NVST | Pierce James Andrew | Dir | A - Grant | $0.00 | +9,330 | 18.5K | +102% | $0 | |
| 2026-05-21 16:36 | 2026-05-19 | NVST | Raskas Daniel | Dir | A - Grant | $0.00 | +9,330 | 54.0K | +21% | $0 | |
| 2026-05-21 16:36 | 2026-05-19 | NVST | Huennekens R Scott | Dir | A - Grant | $0.00 | +12.6K | 82.1K | +18% | $0 | |
| D | 2026-02-27 | 2026-02-25 | NVST | Keel Paul A | CEO, Dir | A - Grant | $0.00 | +48.7K | 384.4K | +14% | $0 |
| D | 2026-02-27 | 2026-02-25 | NVST | Keel Paul A | CEO, Dir | F - Tax | $29.59 | -11.8K | 335.7K | -3% | -$350.3K |
| D | 2026-02-27 | 2026-02-25 | NVST | Nilsson Stefan | Pres, Nobel Biocare | F - Tax | $29.59 | -182 | 54.8K | -0.3% | -$5,385 |
| D | 2026-02-27 | 2026-02-25 | NVST | Nilsson Stefan | Pres, Nobel Biocare | A - Grant | $0.00 | +7,605 | 62.4K | +14% | $0 |
| D | 2026-02-27 | 2026-02-25 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | F - Tax | $29.59 | -2,976 | 29.4K | -9% | -$88.1K |
| D | 2026-02-27 | 2026-02-25 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | A - Grant | $0.00 | +5,915 | 35.3K | +20% | $0 |
| D | 2026-02-27 | 2026-02-25 | NVST | Befidi Robert | Pres, Diagnostics | F - Tax | $29.59 | -2,177 | 43.3K | -5% | -$64.4K |
| D | 2026-02-27 | 2026-02-25 | NVST | Befidi Robert | Pres, Diagnostics | A - Grant | $0.00 | +7,605 | 50.9K | +18% | $0 |
| D | 2026-02-27 | 2026-02-25 | NVST | Nance Mark E | GC | A - Grant | $0.00 | +12.7K | 81.3K | +18% | $0 |
| D | 2026-02-27 | 2026-02-25 | NVST | Nance Mark E | GC | F - Tax | $29.59 | -3,368 | 68.6K | -5% | -$99.7K |
| D | 2026-02-27 | 2026-02-25 | NVST | Acurio Veronica | Pres, Orthodontics | F - Tax | $29.59 | -1,412 | 48.9K | -3% | -$41.8K |
| D | 2026-02-27 | 2026-02-25 | NVST | Acurio Veronica | Pres, Orthodontics | A - Grant | $0.00 | +7,605 | 56.5K | +16% | $0 |
| D | 2026-02-27 | 2026-02-25 | NVST | Hammes Eric D. | CFO | F - Tax | $29.59 | -2,045 | 94.7K | -2% | -$60.5K |
| D | 2026-02-27 | 2026-02-25 | NVST | Hammes Eric D. | CFO | A - Grant | $0.00 | +16.1K | 110.8K | +17% | $0 |
| 2026-02-27 | 2026-02-25 | NVST | Kaabi Faez C | CAO | F - Tax | $29.59 | -4,964 | 45.0K | -10% | -$146.9K | |
| 2026-02-27 | 2026-02-25 | NVST | Kaabi Faez C | CAO | A - Grant | $0.00 | +13.5K | 58.6K | +30% | $0 | |
| DM | 2026-02-11 | 2026-02-10 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | S - Sale+OE | $30.00 | -9,675 | 32.4K | -23% | -$290.2K |
| DM | 2026-02-11 | 2026-02-10 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | M - OptEx | $17.25 | +9,675 | 38.0K | +34% | +$166.9K |
| 2025-11-04 | 2025-11-01 | NVST | Keel Paul A | CEO, Dir | F - Tax | $20.35 | -54.1K | 347.6K | -13% | -$1.10M | |
| 2025-08-27 | 2025-08-25 | NVST | Nilsson Stefan | Pres, Nobel Biocare | F - Tax | $21.12 | -804 | 54.9K | -1% | -$17.0K | |
| 2025-08-27 | 2025-08-25 | NVST | Acurio Veronica | Pres, Orthodontics | F - Tax | $21.12 | -5,422 | 50.3K | -10% | -$114.5K | |
| 2025-08-27 | 2025-08-25 | NVST | Befidi Robert | Pres, Diagnostics | F - Tax | $21.12 | -3,454 | 45.5K | -7% | -$72.9K | |
| 2025-08-27 | 2025-08-25 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | S - Sale | $21.60 | -15.0K | 32.4K | -32% | -$324.0K | |
| 2025-08-27 | 2025-08-25 | NVST | Hammes Eric D. | CFO | F - Tax | $21.12 | -7,654 | 96.8K | -7% | -$161.7K | |
| 2025-07-16 | 2025-07-14 | NVST | Pierce James Andrew | Dir | A - Grant | $0.00 | +9,155 | 9,155 | New | $0 | |
| 2025-06-12 | 2025-06-10 | NVST | Hulit Barbara B. | Dir | A - Grant | $0.00 | +10.4K | 79.8K | +15% | $0 | |
| 2025-06-12 | 2025-06-10 | NVST | GALLAHUE KIERAN | Dir | A - Grant | $0.00 | +10.4K | 44.7K | +31% | $0 | |
| 2025-06-12 | 2025-06-10 | NVST | Huennekens R Scott | Dir | A - Grant | $0.00 | +14.4K | 69.5K | +26% | $0 | |
| 2025-06-12 | 2025-06-10 | NVST | Jain Vivek | Dir | A - Grant | $0.00 | +10.4K | 43.6K | +32% | $0 | |
| 2025-06-12 | 2025-06-10 | NVST | TSINGOS CHRISTINE A | Dir | A - Grant | $0.00 | +10.4K | 50.6K | +26% | $0 | |
| 2025-06-12 | 2025-06-10 | NVST | Raskas Daniel | Dir | A - Grant | $0.00 | +10.4K | 44.7K | +31% | $0 | |
| 2025-06-12 | 2025-06-10 | NVST | Carruthers Wendy | Dir | A - Grant | $0.00 | +10.4K | 50.6K | +26% | $0 | |
| 2025-05-27 | 2025-05-25 | NVST | Keel Paul A | CEO, Dir | F - Tax | $16.72 | -12.8K | 401.7K | -3% | -$213.8K | |
| D | 2025-02-27 | 2025-02-25 | NVST | Nance Mark E | GC | A - Grant | $0.00 | +18.2K | 71.9K | +34% | $0 |
| D | 2025-02-27 | 2025-02-25 | NVST | Nance Mark E | GC | F - Tax | $20.66 | -3,691 | 53.8K | -6% | -$76.3K |
| D | 2025-02-27 | 2025-02-25 | NVST | Kaabi Faez C | CAO | A - Grant | $0.00 | +9,685 | 50.0K | +24% | $0 |
| D | 2025-02-27 | 2025-02-25 | NVST | Kaabi Faez C | CAO | F - Tax | $20.66 | -4,319 | 40.3K | -10% | -$89.2K |
| D | 2025-02-27 | 2025-02-26 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | A - Grant | $0.00 | +8,475 | 47.4K | +22% | $0 |
| D | 2025-02-27 | 2025-02-25 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | F - Tax | $20.66 | -3,813 | 38.9K | -9% | -$78.8K |
| D | 2025-02-27 | 2025-02-25 | NVST | Keel Paul A | CEO, Dir | A - Grant | $0.00 | +65.8K | 414.4K | +19% | $0 |
| D | 2025-02-27 | 2025-02-25 | NVST | Hammes Eric D. | CFO | A - Grant | $0.00 | +15.7K | 104.4K | +18% | $0 |
| D | 2025-02-27 | 2025-02-25 | NVST | Nilsson Stefan | Pres, Nobel Biocare | A - Grant | $0.00 | +10.3K | 55.7K | +23% | $0 |
| D | 2025-02-27 | 2025-02-25 | NVST | Acurio Veronica | Pres, Orthodontics | A - Grant | $0.00 | +10.3K | 55.7K | +23% | $0 |
| D | 2025-02-27 | 2025-02-25 | NVST | Befidi Robert | Pres, Diagnostics | F - Tax | $20.66 | -1,123 | 38.7K | -3% | -$23.2K |
| D | 2025-02-27 | 2025-02-25 | NVST | Befidi Robert | Pres, Diagnostics | A - Grant | $0.00 | +10.3K | 49.0K | +27% | $0 |
| 2024-11-04 | 2024-11-01 | NVST | Keel Paul A | CEO, Dir | F - Tax | $20.94 | -54.0K | 348.6K | -13% | -$1.13M | |
| 2024-09-19 | 2024-09-17 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | F - Tax | $19.00 | -812 | 42.7K | -2% | -$15.4K | |
| D | 2024-08-27 | 2024-08-25 | NVST | Befidi Robert | Pres, Diagnostics | F - Tax | $18.70 | -3,454 | 39.8K | -8% | -$64.6K |
| 2024-08-27 | 2024-08-25 | NVST | Hammes Eric D. | CFO | A - Grant | $0.00 | +64.2K | 88.7K | +262% | $0 | |
| 2024-08-14 | 2024-08-13 | NVST | Keel Paul A | CEO, Dir | P - Purchase | $16.87 | +30.0K | 402.6K | +8% | +$506.1K | |
| 2024-08-13 | 2024-08-12 | NVST | Hammes Eric D. | CFO | P - Purchase | $16.33 | +24.5K | 24.5K | New | +$400.6K | |
| 2024-07-17 | 2024-07-15 | NVST | Nance Mark E | GC | F - Tax | $15.94 | -491 | 57.5K | -0.8% | -$7,827 | |
| 2024-06-27 | 2024-06-25 | NVST | Keller Stephen | Principal Financial Off | A - Grant | $0.00 | +31.2K | 53.8K | +139% | $0 | |
| DM | 2024-05-29 | 2024-05-25 | NVST | Keel Paul A | CEO, Dir | A - Grant | $0.00 | +372.6K | 372.6K | New | $0 |
| 2024-05-29 | 2024-05-25 | NVST | Conley Eric | SVP, Orthodontics | F - Tax | $18.25 | -642 | 53.2K | -1% | -$11.7K | |
| 2024-05-23 | 2024-05-21 | NVST | Carruthers Wendy | Dir | A - Grant | $0.00 | +10.1K | 40.2K | +34% | $0 | |
| 2024-05-23 | 2024-05-21 | NVST | TSINGOS CHRISTINE A | Dir | A - Grant | $0.00 | +10.1K | 40.1K | +34% | $0 | |
| 2024-05-23 | 2024-05-21 | NVST | Huennekens R Scott | Dir | A - Grant | $0.00 | +14.2K | 55.1K | +35% | $0 | |
| 2024-05-23 | 2024-05-21 | NVST | GALLAHUE KIERAN | Dir | A - Grant | $0.00 | +10.1K | 34.2K | +42% | $0 | |
| 2024-05-23 | 2024-05-21 | NVST | Jain Vivek | Dir | A - Grant | $0.00 | +10.1K | 33.2K | +44% | $0 | |
| 2024-05-23 | 2024-05-21 | NVST | Hulit Barbara B. | Dir | A - Grant | $0.00 | +10.1K | 69.4K | +17% | $0 | |
| 2024-05-23 | 2024-05-21 | NVST | Raskas Daniel | Dir | A - Grant | $0.00 | +10.1K | 34.2K | +42% | $0 | |
| 2024-04-16 | 2024-04-15 | NVST | Hulit Barbara B. | Dir | A - Grant | $0.00 | +13.1K | 59.3K | +28% | $0 | |
| 2024-03-18 | 2024-03-15 | NVST | Hulit Barbara B. | Dir | A - Grant | $0.00 | +11.7K | 46.2K | +34% | $0 | |
| D | 2024-02-27 | 2024-02-25 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | F - Tax | $22.65 | -4,134 | 27.0K | -13% | -$93.6K |
| D | 2024-02-27 | 2024-02-25 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | A - Grant | $0.00 | +16.6K | 43.5K | +61% | $0 |
| D | 2024-02-27 | 2024-02-25 | NVST | Nance Mark E | GC | F - Tax | $22.65 | -2,600 | 36.4K | -7% | -$58.9K |
| D | 2024-02-27 | 2024-02-25 | NVST | Nance Mark E | GC | A - Grant | $0.00 | +21.5K | 58.0K | +59% | $0 |
| D | 2024-02-27 | 2024-02-25 | NVST | Aghdaei Amir | CEO, Dir | F - Tax | $22.65 | -33.4K | 262.0K | -11% | -$755.8K |
| D | 2024-02-27 | 2024-02-25 | NVST | Aghdaei Amir | CEO, Dir | A - Grant | $0.00 | +48.6K | 310.6K | +19% | $0 |
| D | 2024-02-27 | 2024-02-25 | NVST | Befidi Robert | Pres, Diagnostics | A - Grant | $0.00 | +9,385 | 43.2K | +28% | $0 |
| D | 2024-02-27 | 2024-02-25 | NVST | Conley Eric | SVP, Orthodontics | F - Tax | $22.65 | -1,241 | 46.1K | -3% | -$28.1K |
| D | 2024-02-27 | 2024-02-25 | NVST | Conley Eric | SVP, Orthodontics | A - Grant | $0.00 | +7,730 | 53.9K | +17% | $0 |
| D | 2024-02-27 | 2024-02-25 | NVST | Kaabi Faez C | CAO | A - Grant | $0.00 | +30.9K | 44.6K | +225% | $0 |
| D | 2024-02-27 | 2024-02-25 | NVST | Kaabi Faez C | CAO | F - Tax | $22.65 | -1,505 | 13.7K | -10% | -$34.1K |
| D | 2024-02-27 | 2024-02-25 | NVST | Keller Stephen | Principal Financial Off | F - Tax | $22.65 | -1,562 | 11.5K | -12% | -$35.4K |
| D | 2024-02-27 | 2024-02-25 | NVST | Keller Stephen | Principal Financial Off | A - Grant | $0.00 | +11.0K | 22.6K | +96% | $0 |
| 2024-02-20 | 2024-02-15 | NVST | Hulit Barbara B. | Dir | A - Grant | $0.00 | +22.2K | 34.5K | +181% | $0 | |
| M | 2023-11-20 | 2023-11-16 | NVST | Conley Eric | SVP, Orthodontics | P - Purchase | $22.89 | +2,185 | 47.4K | +5% | +$50.0K |
| 2023-11-09 | 2023-11-08 | NVST | Nance Mark E | GC | P - Purchase | $21.75 | +5,000 | 39.0K | +15% | +$108.8K | |
| 2023-11-07 | 2023-11-06 | NVST | Keller Stephen | Principal Financial Off | P - Purchase | $21.53 | +2,000 | 13.1K | +18% | +$43.1K | |
| M | 2023-11-07 | 2023-11-06 | NVST | Aghdaei Amir | CEO, Dir | P - Purchase | $21.53 | +10.0K | 295.4K | +4% | +$215.3K |
| 2023-09-18 | 2023-09-17 | NVST | Aghdaei Amir | CEO, Dir | F - Tax | $28.87 | -18.4K | 285.4K | -6% | -$531.0K | |
| 2023-09-18 | 2023-09-17 | NVST | Eriksson Patrik | SVP | F - Tax | $28.87 | -1,298 | 79.7K | -2% | -$37.5K | |
| 2023-09-18 | 2023-09-17 | NVST | Yu Howard H | CFO | F - Tax | $28.87 | -1,965 | 43.9K | -4% | -$56.7K | |
| 2023-09-18 | 2023-09-17 | NVST | Reis Mischa | SVP, Strategy, Bus. Dev | F - Tax | $28.87 | -787 | 31.1K | -2% | -$22.7K |
Purchase Sale Sale after option exercise All abbreviations